Triastek 3DµS - Model GR - 3D Microstructure Technology for Gastric Retention
Triastek's 3DuS-GR technology is designed for targeted drug delivery to the stomach, allowing the product to remain in the gastric region for a pre-determined duration. This system is capable of customizing drug release profiles to achieve either extended-release or pulsatile-release, thereby potentially enhancing the absorption of active pharmaceutical ingredients and increasing drug efficacy. The sustained presence in the upper gastrointestinal tract can lead to better oral bioavailability. Furthermore, the 3DμS®-GR system simplifies dosing regimens and improves clinical efficacy, while ensuring medication safety. The platform is backed by image tracking technology, contributing to accurate monitoring and administration. These features together aim to streamline treatment protocols in clinical environments.
Simplify Dosing Regimen
By prolonging the drug release time in the stomach, the dosage regimen can be simplified to reduce the pill burden and improve the long-term medication compliance of patients.
Improve Clinical Efficacy
Gastric retention products can extend the release time of the drug in the stomach, increase drug absorption in the gastrointestinal tract, and improve the therapeutic efficacy.
Ensure Medication Safety
The capsule shell keeps the bloom structure in folded state before entering the stomach. Rounded corner design to avoid any gastric damage. Bloom structure will be departed within a designated time period and excreted from the pylorus.
Image Tracking Technology
Tracking agents for X-ray imaging are 3D printed in the structure to precisely track their gastric retention and Gl transition.
3DμS-GR enables sustained absorption of drugs in the upper GI tract to improve oral bioavailability.
- Sustained Absorption in Upper GI
- Improve Oral Bioavailability
3DμS-GR achieves long-term and stable retention of drugs in the stomach through its special bloom structure design.